THE TRAVEL TRIAL: Transcatheter Right Atrial-ventricular Valve rEplacement With LuX-Valve

NARecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

June 16, 2020

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Tricuspid Valve Insufficiency
Interventions
DEVICE

Tricuspid Valve Replacement System

To eliminate the tricuspid regurgitation through orthotopically replacing tricuspid valve with LuX-Valve system.

Trial Locations (8)

100029

RECRUITING

Beijing Anzhen Hospital, Beijing

100037

RECRUITING

Fu Wai Hospital, Beijing

200433

RECRUITING

Changhai Hospital, Shanghai

310000

RECRUITING

The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou

430000

RECRUITING

Wuhan Union Hospital, Wuhan

510000

RECRUITING

Guangdong Provincial People's Hospital, Guangzhou

610000

RECRUITING

West China Hospital, Chengdu

710000

RECRUITING

Xijing Hospital, Xi'an

All Listed Sponsors
collaborator

Fu Wai Hospital, Beijing, China

OTHER

collaborator

Beijing Anzhen Hospital

OTHER

collaborator

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

OTHER

collaborator

West China Hospital

OTHER

collaborator

Xijing Hospital

OTHER

collaborator

Guangdong Provincial People's Hospital

OTHER

collaborator

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

lead

Changhai Hospital

OTHER